Literature DB >> 3890914

Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.

M J Hastings, J Neil, C S Easmon.   

Abstract

Luminol-dependent phagocytic chemiluminescence was used to measure opsonins to group B Streptococcus type III in serum samples from pregnant women. Mean levels were similar amongst patients colonized with this organism and those who were not. Values remained fairly constant for individual women during pregnancy apart from a small, but consistant fall in cord blood samples. Again using luminol-dependent chemiluminescence, 54 clinical isolates of group B Streptococcus type III were evaluated for susceptibility to serum opsonization. Six were found to be resistant and these originated from both colonized babies and babies with systemic GBS infections. Further studies demonstrated strain-to-strain variation in the degree of dependence on both heat-labile and heat-stable opsonins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890914      PMCID: PMC2041062     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  The development of a phage-typing system for group-B streptococci.

Authors:  J Stringer
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

3.  Variations in the opsonic requirements of group B streptococcus type III.

Authors:  M J Hastings; C S Easmon
Journal:  Br J Exp Pathol       Date:  1981-10

4.  The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence.

Authors:  C S Easmon; P J Cole; A J Williams; M Hastings
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

5.  Complement in the newborn infant.

Authors:  R B Johnston; K M Altenburger; A W Atkinson; R H Curry
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

6.  Prevalence of type-specific group B streptococcal antibody in pregnant women.

Authors:  L C Vogel; K M Boyer; C A Gadzala; S P Gotoff
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

7.  The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.

Authors:  C J Baker; B J Webb; D L Kasper; M D Yow; C W Beachler
Journal:  Am J Obstet Gynecol       Date:  1980-05-01       Impact factor: 8.661

8.  Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.

Authors:  C J Baker; M S Edwards; D L Kasper
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124

9.  Group B meningococcal opsonins in serum measured by polymorphonuclear leukocyte chemiluminescence.

Authors:  V Lehmann; C O Solberg
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-08

10.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

  10 in total
  1 in total

Review 1.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.